NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 25 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $113,000 | +41.2% | 15,000 | +33.1% | 0.05% | -21.3% |
| Q1 2020 | $80,000 | +1900.0% | 11,270 | +1602.4% | 0.06% | +6000.0% |
| Q4 2019 | $4,000 | -95.3% | 662 | -96.2% | 0.00% | -96.2% |
| Q3 2019 | $86,000 | – | 17,291 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |